Emory Investigational Drug Services

Atlanta, Georgia 30322

We've found

1 trials

at this facility

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Atlanta, GA

Use our guide to learn which trials are right for you!